Showing 981 - 1,000 results of 225,785 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( a ((mean decrease) OR (a decrease)) ))', query time: 2.10s Refine Results
  1. 981
  2. 982

    Nilotinib decreases HEI-193 cell viability in a time-, dose-, and growth condition- dependent manner. by Nesrin Sabha (127278)

    Published 2013
    “…Trypan blue viability assay shows decreased number of viable cells at 5 days in 3 µM nilotinib, compared to vehicle shown, mean and SD of six technical replicates. …”
  3. 983

    YKL-40 levels decreased during the intensive anti-rheumatic treatment with a combination of csDMARDs. by Tuija Väänänen (4392307)

    Published 2017
    “…YKL-40 levels decreased significantly (p<0.001) during the first four weeks of treatment with csDMARDs; when infliximab (or placebo) was added to the treatment there was a minor further decrease (groups combined, p = 0.031) but no difference between placebo and infliximab treatment groups was found. …”
  4. 984
  5. 985

    Fig 2A–2C and 2G–2L Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    “…We observed a marked decrease in nocturnal locomotion of <i>Opn5</i><sup><i>cre</i></sup><i>; Gnas</i><sup><i>fl/fl</i></sup> mice at both 28°C and 22°C, but no overall differences in energy expenditure, respiratory exchange, or food and water consumption. …”
  6. 986
  7. 987
  8. 988

    Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

    Published 2008
    “…Data represent mean±S.D. F. Collagen of corneal stroma is decreased in <i>Slc39a13</i>-KO mice. …”
  9. 989
  10. 990
  11. 991
  12. 992
  13. 993

    Blocking TNF or IL-6 decreases HIV-1 replication significantly in a dose dependent manner. by Shahin Ranjbar (66979)

    Published 2013
    “…Virus replication was further significantly inhibited in cultures containing a mixture of blocking antibodies to TNF, IL-6, and MCP-1 at a concentration of 2 µg/ml and 5 µg/ml (**, p<0.01). …”
  14. 994
  15. 995
  16. 996
  17. 997
  18. 998
  19. 999
  20. 1000